Novo Nordisk's Q2 profit beats forecasts, raises outlook - Reuters
Novo Nordisk's Q2 profit beats forecasts, raises outlook Reuters
Coverage by Political Leaning
See how different sides of the spectrum reported this story
Tags
All Coverage
<a href="https://news.google.com/rss/articles/CBMiqwFBVV95cUxNdXlQZTlFQVdGcUJLekdBcDJSVHlDeXcwTjdJWFZNWTFSZ083NV90WXFVNkdhVXlRN2JKbHF0c000Y1AxX0VPMDBqeURUaHpfUFcxd2ZFQ1VoQTNBWDVHVkhBZHpWY1oxbnRIU2ZwS3ZONHhmZUF4SVdrNTVkdkdGak1FcFZsdkRwZWlEX0ZOTjRDN3RpOVBZR1hLTEdxSzlRM3lmZ01KYkFOM2c?oc=5" target="_blank">Novo Nordisk's Q2 profit beats forecasts, raises outlook</a> <font color="#6f6f6f">Reuters</font>
Similar Stories
Related coverage based on topic and tags
Uniqlo owner Fast Retailing posts record profit as Western sales overtake China - Reuters
Uniqlo owner Fast Retailing posts record profit as Western sales overtake China Reuters
October 8, 2026 at 06:40 AMSamsung's Q3 profit seen jumping nine-fold, but chip margins may be flat - Reuters
Samsung's Q3 profit seen jumping nine-fold, but chip margins may be flat Reuters
October 6, 2026 at 11:09 PMPanmure Liberum forecasts S&P 500 falling to 5,000, warns bull run nearing end - Reuters
Panmure Liberum forecasts S&P 500 falling to 5,000, warns bull run nearing end Reuters
October 5, 2026 at 08:08 AMVietnam's quarterly GDP grows fastest in 4 years as exports boom - Reuters
Vietnam's quarterly GDP grows fastest in 4 years as exports boom Reuters
October 3, 2026 at 01:11 AMUS FDA extends review of Novo Nordisk's hemophilia drug over facility issues - Reuters
US FDA extends review of Novo Nordisk's hemophilia drug over facility issues Reuters
October 2, 2026 at 09:52 PMMcCormick's price hikes spice up quarterly results despite sluggish demand - Reuters
McCormick's price hikes spice up quarterly results despite sluggish demand Reuters
October 1, 2026 at 06:37 PM